These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21383062)

  • 1. Nuclear but not cytosolic phosphoinositide 3-kinase beta has an essential function in cell survival.
    Kumar A; Redondo-Muñoz J; Perez-García V; Cortes I; Chagoyen M; Carrera AC
    Mol Cell Biol; 2011 May; 31(10):2122-33. PubMed ID: 21383062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p110α and p110β isoforms of PI3K are involved in protection against H
    Singh P; Bano N; Hossain MM; Basit R; Dar MJ
    Breast Cancer; 2019 May; 26(3):378-385. PubMed ID: 30499025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A biochemical mechanism for the oncogenic potential of the p110beta catalytic subunit of phosphoinositide 3-kinase.
    Dbouk HA; Pang H; Fiser A; Backer JM
    Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19897-902. PubMed ID: 21030680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoinositide 3-kinase β regulates chromosome segregation in mitosis.
    Silió V; Redondo-Muñoz J; Carrera AC
    Mol Biol Cell; 2012 Dec; 23(23):4526-42. PubMed ID: 23051731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMOylation modulates the stability and function of PI3K-p110β.
    El Motiam A; de la Cruz-Herrera CF; Vidal S; Seoane R; Baz-Martínez M; Bouzaher YH; Lecona E; Esteban M; Rodríguez MS; Vidal A; Collado M; Rivas C
    Cell Mol Life Sci; 2021 Apr; 78(8):4053-4065. PubMed ID: 33834259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of GFP-Fusion p110α and p110β Isoforms of PI3K Signaling Pathway in Normal and Cancer Cells.
    Singh P; Dar MS; Singh G; Jamwal G; Sharma PR; Ahmad M; Dar MJ
    J Cell Biochem; 2016 Dec; 117(12):2864-2874. PubMed ID: 27167447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases.
    Dornan GL; Burke JE
    Front Immunol; 2018; 9():575. PubMed ID: 29616047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p110α and p110β isoforms of PI3K signaling: are they two sides of the same coin?
    Singh P; Dar MS; Dar MJ
    FEBS Lett; 2016 Sep; 590(18):3071-82. PubMed ID: 27552098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.
    Geering B; Cutillas PR; Nock G; Gharbi SI; Vanhaesebroeck B
    Proc Natl Acad Sci U S A; 2007 May; 104(19):7809-14. PubMed ID: 17470792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct and opposing roles for the phosphatidylinositol 3-OH kinase catalytic subunits p110α and p110β in the regulation of insulin secretion from rodent and human beta cells.
    Kolic J; Spigelman AF; Plummer G; Leung E; Hajmrle C; Kin T; Shapiro AM; Manning Fox JE; MacDonald PE
    Diabetologia; 2013 Jun; 56(6):1339-49. PubMed ID: 23568272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific function of phosphoinositide 3-kinase beta in the control of DNA replication.
    Marqués M; Kumar A; Poveda AM; Zuluaga S; Hernández C; Jackson S; Pasero P; Carrera AC
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7525-30. PubMed ID: 19416922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p110beta is up-regulated during differentiation of 3T3-L1 cells and contributes to the highly insulin-responsive glucose transport activity.
    Asano T; Kanda A; Katagiri H; Nawano M; Ogihara T; Inukai K; Anai M; Fukushima Y; Yazaki Y; Kikuchi M; Hooshmand-Rad R; Heldin CH; Oka Y; Funaki M
    J Biol Chem; 2000 Jun; 275(23):17671-6. PubMed ID: 10748220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma.
    Guillermet-Guibert J; Bjorklof K; Salpekar A; Gonella C; Ramadani F; Bilancio A; Meek S; Smith AJ; Okkenhaug K; Vanhaesebroeck B
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8292-7. PubMed ID: 18544649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of class IA phosphoinositide 3-kinase catalytic subunits p110 alpha and beta by protease-activated receptor 2 and beta-arrestins.
    Wang P; Kumar P; Wang C; Defea KA
    Biochem J; 2007 Dec; 408(2):221-30. PubMed ID: 17680774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoinositide 3-kinases p110alpha and p110beta regulate cell cycle entry, exhibiting distinct activation kinetics in G1 phase.
    Marqués M; Kumar A; Cortés I; Gonzalez-García A; Hernández C; Moreno-Ortiz MC; Carrera AC
    Mol Cell Biol; 2008 Apr; 28(8):2803-14. PubMed ID: 18285463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells.
    Zhao JJ; Liu Z; Wang L; Shin E; Loda MF; Roberts TM
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18443-8. PubMed ID: 16339315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class IA Phosphatidylinositol 3-Kinase Isoform p110α Mediates Vascular Remodeling.
    Vantler M; Jesus J; Leppänen O; Scherner M; Berghausen EM; Mustafov L; Chen X; Kramer T; Zierden M; Gerhardt M; Ten Freyhaus H; Blaschke F; Sterner-Kock A; Baldus S; Zhao JJ; Rosenkranz S
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1434-44. PubMed ID: 25908763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell activation-induced phosphoinositide 3-kinase alpha/beta dimerization regulates PTEN activity.
    Pérez-García V; Redondo-Muñoz J; Kumar A; Carrera AC
    Mol Cell Biol; 2014 Sep; 34(18):3359-73. PubMed ID: 24958106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER
    Hosford SR; Dillon LM; Bouley SJ; Rosati R; Yang W; Chen VS; Demidenko E; Morra RP; Miller TW
    Clin Cancer Res; 2017 Jun; 23(11):2795-2805. PubMed ID: 27903677
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of a tumor-associated activating mutation of the p110β PI 3-kinase.
    Dbouk HA; Khalil BD; Wu H; Shymanets A; Nürnberg B; Backer JM
    PLoS One; 2013; 8(5):e63833. PubMed ID: 23734178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.